# Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes

> **NCT02469519** · PHASE2,PHASE3 · COMPLETED · sponsor: **Pediatrix** · enrollment: 194 (actual)

## Conditions studied

- Premature Birth

## Interventions

- **DRUG:** Betamethasone - ACTIVE
- **OTHER:** Normal Saline - PLACEBO

## Key facts

- **NCT ID:** NCT02469519
- **Lead sponsor:** Pediatrix
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-03
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-10-31
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2022-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02469519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02469519, "Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02469519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*